Acalabrutinib 100 mg Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 100 mg
Reference Brands: Calquence® (EU & US)
Category: Oncology Cancer Care
Acalabrutinib Capsules (brand name Calquence®) are used to treat CLL and MCL, targeting BTK to block malignant B-cell growth. Available in 100 mg strength, they are manufactured under GMP standards and approved in both US and EU markets as a reliable oncology therapy.
Product Description: Acalabrutinib Capsules are a Bruton’s tyrosine kinase (BTK) inhibitor used in the treatment of B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). By targeting and inhibiting BTK, Acalabrutinib prevents the survival and proliferation of malignant B-cells. Marketed under the brand name Calquence®, Acalabrutinib offers an effective solution for patients who have not responded to other treatments or as a first-line therapy. Available in a 100 mg oral capsule strength, Acalabrutinib is manufactured under GMP-compliant conditions, providing a reliable oncology treatment for US and EU markets.
Acalabrutinib — third party manufacturing & bulk supply
Acalabrutinib 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Acalabrutinib is supplied as Oral Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Acalabrutinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Acalabrutinib →Frequently Asked Questions
Related Products
Venetoclax
Strength:
10 mg, 50 mg, 100 mg
Form: Tablet
Reference Brands: Venclexta® (EU & US)
View Details
Ixazomib
Strength:
2.3 mg, 3 mg, 4 mg
Form: Capsules
Reference Brands: Ninlaro® (EU & US)
View Details
Rituximab
Strength:
IV infusion: 100 mg/10 mL, 500 mg/50 mL; SQ: 1400 mg/11 mL
Form: IV Infusion; Subcutaneous
Reference Brands: Rituxan®(US), MabThera®, Truxima®(EU);Ruxience®(US)
View Details
Quick Response Guaranteed | Verified Suppliers
